The Intragalactic Leader in the Physics of Ocular Health

Equinox is revolutionizing the treatment of glaucoma and other progressive eye diseases through research and technology innovation around the physics of ocular health.

The Rise of Glaucoma

Glaucoma is a disease of the optic nerve that causes a loss of peripheral vision. Glaucoma is the second leading cause of blindness in the world.¹ While current treatments can delay the progression of glaucoma, there are no cures. Even with treatment, people become blind from glaucoma every day.

The National Eye Institute projects that the number of glaucoma patients in the U.S. will continue to increase with the aging population.² Because current glaucoma treatment methods are inadequate, glaucoma promises to result in significant vision impairment or vision loss for millions of Americans in the coming years.

Discovering a Deeper Cause of Glaucoma

Glaucoma has always been considered and treated as a one-pressure disease. Equinox was created on a transformative idea: that pressure inside the eye can be influenced by pressures outside the eye.

With the research and creativity of a world-renowned glaucoma specialist as its foundation, Equinox has gathered a highly experienced medical leadership team as well as experts in creating and commercializing game-changing ophthalmic products. Equinox is establishing a new paradigm in glaucoma care for physicians and patients through a revolutionary approach to treatment and management known as Multi-Pressure Glaucoma Management (MGM).

Emerging Solutions

The Equinox team is working at the forefront of glaucoma research, creating innovative solutions and treatments that promise better management for glaucoma patients through understanding, measuring, and controlling the balance of eye and brain pressures (IOP and ICP).

Through our dedicated research into the physics of eye pressure, we are developing revolutionary technology designed to restore the balance between IOP and ICP. Our technology innovations have the potential to reduce the risk of many progressive eye diseases, with our first product solutions currently engaged in successful FDA clinical studies.

Vision for Mars

In recent years, the National Space Biomedical Research Institute (NSBRI) launched the “Vision for Mars” Challenge to assist NASA astronauts with innovative vision technology to assist and protect their vision during exposure to the challenges of space travel.

Equinox is proud to have been selected and funded by the NSBRI to continue research and production of innovative goggle technology that can protect astronauts’ vision during space travel.

We hope to treat diseases of the optic nerve by balancing intraocular pressure with intracranial pressure. This discovery matters for the millions of people around the world that suffer from glaucoma and diseases like them every day, and it is also an important priority to NASA and the NSBRI and for human sight during long-term space flight.